Ellis Investment Partners, LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 67 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 1.4%.

Quarter-by-quarter ownership
Ellis Investment Partners, LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$8,000
-27.3%
2,8000.0%0.00%
-33.3%
Q1 2022$11,000
-15.4%
2,8000.0%0.00%0.0%
Q4 2021$13,000
+18.2%
2,8000.0%0.00%0.0%
Q3 2021$11,0000.0%2,8000.0%0.00%0.0%
Q2 2021$11,000
-15.4%
2,800
-9.7%
0.00%
-25.0%
Q1 2021$13,000
+8.3%
3,1000.0%0.00%0.0%
Q4 2020$12,0000.0%3,1000.0%0.00%0.0%
Q3 2020$12,000
-14.3%
3,1000.0%0.00%
-20.0%
Q2 2020$14,0000.0%3,1000.0%0.01%
-28.6%
Q1 2020$14,0003,1000.01%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,914,970$81,007,00029.87%
RTW INVESTMENTS, LP 1,080,331$30,022,0009.33%
Avoro Capital Advisors LLC 804,299$22,351,0005.81%
ACUTA CAPITAL PARTNERS, LLC 122,222$3,397,0001.97%
Broadfin Capital, LLC 1,095,373$30,440,0001.69%
Belmont Global Advisors, Inc. 35,000$973,0001.65%
P.A.W. CAPITAL CORP 48,000$1,334,0001.53%
Perceptive Advisors 1,309,030$36,378,0001.45%
Iguana Healthcare Management, LLC 125,000$3,474,0001.37%
EAM Investors, LLC 97,350$2,705,0000.43%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders